New York , NY (PressExposure) May 01, 2011 -- The Farber Center for Radiation Oncology has become the first treatment center in New York City-and the 34th in the world-to treat breast cancer patients with AccuBoost, an innovative new image-guided process designed to offer more targeted, less invasive treatment. AccuBoost is the first technology to allow High Dose Rate (HDR) treatment of breast cancer in a non-invasive way, using digital mammography for localization and surface delivery of radiation. Dr. Leonard Farber, Radiation Oncologist and founder of the Farber Center, is currently treating the first patient to undergo AccuBoost treatment at the center. In keeping with The Farber Center's commitment to state-of-the-art technology and patient comfort, AccuBoost represents cutting-edge, minimally invasive care that puts the patient first.
Prior to the introduction of AccuBoost, partial breast irradiation treatment was performed using more invasive techniques, such as the insertion of multiple protruding catheters or inflatable balloon devices into the breast. AccuBoost allows the physician to see the tissue that needs treatment in real time, enabling radiation oncologists to select the area for radiation just prior to delivery and administer dose only to the tissue requiring treatment. AccuBoost can be delivered either prior to or after the main external beam portion of the patient's treatment. Women receiving treatment can see the real-time imaging as well, making an often intimidating and confusing experience less stressful and more accessible. The breast is immobilized and imaged in a manner similar to mammography but without the excessive pressure that causes discomfort. A special applicator is positioned to deliver the radiation with greater accuracy and virtually eliminate unnecessary exposure to the heart, lungs and chest wall.
"We're so pleased to be able to offer this truly revolutionary treatment at The Farber Center," says Dr. Farber. "AccuBoost offers an ideal treatment for our patients in New York, as it's a short, targeted, non-invasive course that provides a superior level of care and lets our patients live their lives with minimal interference."
At a dedicated suite at the Farber Center, patients will receive AccuBoost treatment daily for five to eight days, with the beam targeting different angles during each treatment to ensure that the entire surface is radiated. The addition of the AccuBoost digital mammography unit promises to give patients in New York City access to the most breakthrough treatment available for the first time, improving outcomes while minimizing side effects.
For more information or to speak with an expert from The Farber Center for Radiation Oncology please contact: Tanya Tohil-Farber at 212 300-0663.